News | Artificial Intelligence | February 13, 2019

Siemens Healthineers Demonstrates Artificial Intelligence, Healthcare Digitalization at HIMSS19

Company will showcase AI Companion applications, inventory management software

Siemens Healthineers Demonstrates Artificial Intelligence, Healthcare Digitalization at HIMSS19

February 13, 2019 — At the 2019 Healthcare Information and Management Systems Society (HIMSS) global conference and exhibition, Feb. 11-15 in Orlando, Fla., Siemens Healthineers will demonstrate how healthcare providers can benefit from digitalization, particularly in the form of artificial intelligence (AI). In addition to its greater digital services portfolio, Siemens Healthineers will showcase two AI-based applications, the AI-Pathway Companion and the AI-Rad Companion.

The company will also present various digital solutions that have the potential to both help improve patient care and help reduce costs. These include several information technology (IT) tools for laboratory diagnostics, as well as the syngo Virtual Cockpit, a solution that enables medical professionals to connect remotely to scanner workplaces to assist personnel at a different location.

Siemens is also currently investigating AI-powered Digital Twin technology, which aims to enable the simulation of individual organ physiology to potentially better understand patient health and predict changes and therapy outcomes.

  • The AI-Pathway Companion, which is currently under development, will be a clinical decision support system based on clinical guideline data imported by AI that can aid physicians in making diagnostic and therapeutic decisions along the clinical pathway. While numerous applications in the healthcare market make the workflows of individual clinical or administrative departments more efficient, the AI-Pathway Companion is designed to help optimize the processes along clinical pathways, and thus support personalized as well as standardized patient management. The design goal of the AI-Pathway Companion is to provide physicians in multi-disciplinary disease boards with the clinical status of each patient, based on data integration and artificial intelligence, and to help make recommendations for next steps to accelerate diagnostic and treatment decisions.
  • The AI-Rad Companion Chest CT, which is pending U.S. Food and Drug Administration (FDA) 510(k) clearance, will be the first intelligent software assistant from Siemens Healthineers for radiology – and the first application of the AI-Rad Companion platform. The AI-Rad Companion Chest CT (computed tomography) is designed to identify anatomies and potentially disease-relevant changes, differentiate between various structures and highlight them individually, and mark and measure potential abnormalities. This applies to organs such as the lungs, heart, aorta and coronary arteries. The software is designed to automatically turn findings into a quantitative report.
  • The syngo Virtual Cockpit software solution, which is not yet commercially available, can be used by medical staff to connect remotely to scanner workplaces to assist personnel at a different location, especially where more sophisticated examinations are required. syngo Virtual Cockpit can be utilized with magnetic resonance imaging (MRI) and MR-positron emission tomography (PET) scanners as well as with CT systems from Siemens Healthineers. With the ability to deploy experienced technologists across multiple locations, healthcare providers can achieve a higher level of standardization that can lead to more accurate diagnoses.

For more information: www.usa.healthcare.siemens.com

Related Content

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017.

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017, and who had health records for at least one year prior to the mammogram. The algorithm was trained on 9,611 mammograms. Image courtesy of Radiology.

Feature | Artificial Intelligence | July 19, 2019 | Michal Chorev
Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer...
Videos | Computed Tomography (CT) | July 19, 2019
Quynh Truong, M.D., MPH, associate professor of radio
Low Doses of Radiation Promote Cancer-capable Cells
News | Radiation Dose Management | July 18, 2019
Low doses of radiation equivalent to three computed tomography (CT) scans, which are considered safe, give cancer-...
Paragon Biosciences Launches Qlarity Imaging to Advance FDA-cleared AI Breast Cancer Diagnosis System

Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire.

Technology | Artificial Intelligence | July 18, 2019
Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded...
Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n
Johns Hopkins Named Qualified Provider-led Entity to Develop Criteria for Diagnostic Imaging
News | Clinical Decision Support | July 18, 2019
On June 30, 2019, the Centers for Medicare & Medicaid Services (CMS) announced the Johns Hopkins University School...
New Lung Ambition Alliance Aims to Double Five-year Lung Cancer Survival by 2025
News | Lung Cancer | July 17, 2019
The International Association for the Study of Lung Cancer (IASLC), Guardant Health, the Global Lung Cancer Coalition (...
Anatomage Releases Anatomage Cloud Platform
News | Remote Viewing Systems | July 16, 2019
Anatomage Inc. released an update to the Anatomage Cloud platform that allows medical and dental professionals to...